Brendan F Gilmore Selected Research

Fibrosis (Cirrhosis)

6/2014

Regulation of TGF-β1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brendan F Gilmore Research Topics

Disease

21	Infections 01/2019 - 11/2008
5	Inflammation (Inflammations) 01/2019 - 11/2008
3	Bacterial Infections (Bacterial Infection) 01/2022 - 08/2010
3	Urinary Tract Infections (Urinary Tract Infection) 10/2021 - 08/2010
3	Neoplasms (Cancer) 12/2018 - 12/2010
2	Dysbiosis 01/2021 - 01/2020
2	Wounds and Injuries (Trauma) 11/2019 - 02/2017
2	Pseudomonas Infections 01/2015 - 01/2012
2	Persistent Infection 01/2012 - 11/2008
2	Phototoxic Dermatitis (Phototoxicity) 07/2006 - 10/2004
1	Proteus Infections 10/2021
1	Necrosis 05/2021
1	Pneumonia (Pneumonitis) 01/2019
1	Osteoporosis 01/2018
1	Colitis 01/2017
1	Rupture 04/2016
1	Cross Infection (Nosocomial Infection) 07/2015
1	Infertility (Sterility) 02/2015
1	Cystic Fibrosis (Mucoviscidosis) 01/2015
1	Hemolysis 09/2014
1	Fibrosis (Cirrhosis) 06/2014
1	Idiopathic Pulmonary Fibrosis 06/2014
1	Communicable Diseases (Infectious Diseases) 03/2013
1	Animal Diseases 05/2012
1	Melanoma (Melanoma, Malignant) 07/2011
1	Asthma (Bronchial Asthma) 03/2011
1	Clostridium Infections 03/2011
1	Keloid 12/2010
1	Cicatrix (Scar) 12/2010
1	Prostatitis 11/2008
1	Neoplasm Metastasis (Metastasis) 07/2006

Drug/Important Bio-Agent (IBA)

9	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 08/2010
5	Biocompatible Materials (Biomaterials)IBA 02/2017 - 07/2012
3	Anti-Infective Agents (Microbicides)IBA 01/2022 - 12/2008
3	EnzymesIBA 10/2021 - 10/2014
3	Peptides (Polypeptides)IBA 01/2019 - 10/2014
3	Proteins (Proteins, Gene)FDA Link 04/2013 - 07/2011
3	Peptide Hydrolases (Proteases)FDA Link 06/2012 - 12/2010
2	Plasma GasesIBA 11/2019 - 12/2018
2	Pharmaceutical PreparationsIBA 01/2015 - 01/2011
2	HydrogelsIBA 10/2014 - 07/2012
2	Antimicrobial PeptidesIBA 07/2012 - 01/2011
2	3-((aminoiminomethyl)thio)-2-propenoic acid (ZAPA)IBA 10/2011 - 11/2008
2	Metalloproteases (Metalloproteinases)IBA 06/2011 - 11/2008
2	Virulence Factors (Pathogenicity Factors)IBA 06/2011 - 11/2008
2	fibroblast activation protein alphaIBA 12/2010 - 07/2006
2	AcidsIBA 07/2006 - 10/2004
1	Polysaccharides (Glycans)IBA 01/2022
1	Disinfectants (Biocides)IBA 05/2021
1	Caspase 3 (Caspase-3)IBA 05/2021
1	Chemotactic FactorsIBA 01/2019
1	CytokinesIBA 01/2019
1	VenomsIBA 01/2019
1	CathelicidinsIBA 01/2019
1	SolutionsIBA 12/2018
1	LipopolysaccharidesIBA 07/2016
1	Sulfhydryl Compounds (Thiols)IBA 04/2016
1	Cysteine Proteases (Cysteine Protease)IBA 04/2016
1	Particulate MatterIBA 04/2016
1	cathepsin SIBA 04/2016
1	Caspase 1 (ICE Protease)IBA 04/2016
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Ionic LiquidsIBA 08/2015
1	Bulk DrugsIBA 02/2015
1	Deoxyribonucleases (DNase)FDA Link 01/2015
1	dornase alfa (Pulmozyme)FDA Link 01/2015
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2015
1	GelsIBA 09/2014
1	Messenger RNA (mRNA)IBA 06/2014
1	Brefeldin AIBA 06/2014
1	Cystatin CIBA 06/2014
1	Indicators and Reagents (Reagents)IBA 05/2012
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2012
1	AminoglycosidesIBA 01/2012
1	Immunoglobulin A (IgA)IBA 10/2011
1	Becaplermin (PDGF-BB)FDA Link 07/2011
1	Pancreatic Elastase (Elastase)IBA 06/2011
1	FluoroquinolonesIBA 03/2011
1	Immunoglobulin G (IgG)IBA 03/2011
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 12/2010
1	Extracellular Matrix ProteinsIBA 12/2010
1	CoagulaseIBA 12/2008
1	EstersIBA 07/2006

Therapy/Procedure

6	Therapeutics 01/2020 - 12/2008
5	Catheters 10/2021 - 08/2010
2	Prostheses and Implants (Prosthesis) 02/2017 - 01/2012
1	Cardiac Catheters 02/2017
1	Length of Stay 10/2015
1	Phage Therapy 10/2011
1	Topical Administration 10/2004